Zurich Cantonal Bank’s Accelerate Diagnostics AXDX Stock Holding History

Zurich Cantonal Bank’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,947	Closed	-$42K	–	2891
2022 Q1	$42K	Hold	2,947	–	–	﹤0.01%	2560
2021 Q4	$154K	Buy	2,947 +2,772	+1,584%	+$154K	﹤0.01%	2253
2021 Q3	$10K	Hold	175	–	–	﹤0.01%	2809
2021 Q2	$14K	Hold	175	–	–	﹤0.01%	2593
2021 Q1	$15K	Hold	175	–	–	﹤0.01%	2535
2020 Q4	$13K	Hold	175	–	–	﹤0.01%	2596
2020 Q3	$19K	Hold	175	–	–	﹤0.01%	2497
2020 Q2	$27K	Hold	175	–	–	﹤0.01%	2397
2020 Q1	$15K	Hold	175	–	–	﹤0.01%	2402
2019 Q4	$30K	Hold	175	–	–	﹤0.01%	2377
2019 Q3	$32K	Hold	175	–	–	﹤0.01%	2280
2019 Q2	$40K	Hold	175	–	–	﹤0.01%	2194
2019 Q1	$37K	Hold	175	–	–	﹤0.01%	2161
2018 Q4	$20K	Hold	175	–	–	﹤0.01%	2445
2018 Q3	$40K	Hold	175	–	–	﹤0.01%	2264
2018 Q2	$39K	Hold	175	–	–	﹤0.01%	2256
2018 Q1	$40K	Hold	175	–	–	﹤0.01%	2191
2017 Q4	$46K	Buy	175 +79	+82%	+$18.5K	﹤0.01%	2116
2017 Q3	$21K	Hold	96	–	–	﹤0.01%	2243
2017 Q2	$26K	Hold	96	–	–	﹤0.01%	2148
2017 Q1	$23K	Hold	96	–	–	﹤0.01%	2241
2016 Q4	$20K	Sell	96 -131	-58%	-$31.1K	﹤0.01%	2268
2016 Q3	$62K	Buy	227 +30	+15%	+$6.64K	﹤0.01%	1522
2016 Q2	$28K	Hold	197	–	–	﹤0.01%	1840
2016 Q1	$28K	Buy	+197	New	+$27.8K	﹤0.01%	1775

Other funds holding AXDX

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Zurich Cantonal Bank's AXDX Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 2,947 shares — an estimated $42K sold.

Zurich Cantonal Bank first reported a position in AXDX in Q1 2016 and held it in 25 quarters. The position peaked at $154K in Q4 2021. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

Zurich Cantonal Bank reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
Zurich Cantonal Bank sold 2,947 Accelerate Diagnostics shares in Q2 2022, an estimated $42K.
Zurich Cantonal Bank first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 25 quarters.
Zurich Cantonal Bank's Accelerate Diagnostics position peaked at $154K in Q4 2021.
74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.